EconomicUnited Kingdom·4 Nov 2026
AbbVie expands Oxford R&D facility with over £120 million investment
AI-summarized · Neutrality-checked
AbbVie expanded its research and development facility located in Oxford, United Kingdom. The project involved an investment of over £120 million.
Loading full story…
Sources and context
Investing.com
Digital newsroomCompany ownedGeographic base not verifiedStandards not yet verified
Source-level context, not a score for this article. Methodology and evidence · Report outdated information
Know where. Know why.